RESEARCH ARTICLE: Assessment of knowledge and awareness regarding opioid overdose and toxicity among a sample of healthcare providers

Authors

  • Fahad Marzouq Alotaibi Saudi Royal land forces, Clinical pharmacy, Khamis Mushayt, Saudi Arabia https://orcid.org/0000-0001-9870-7327
  • Mohammed Fathullah Zaitoun Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia https://orcid.org/0000-0002-1156-9281
  • Rayid Shabeeb Alotabi Ranyah hospital, Taif, Saudi Arabia
  • Mohammed Saeed A. Alhadi Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia
  • Amani Mohammed AlShahrani Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia https://orcid.org/0000-0003-0138-3229
  • Alyah Abdullah Almoeed Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia
  • Marzouq Saeed AlNasser Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia
  • Ghazi Bamagous Umm AlQura university, Makkah, Saudi Arabia https://orcid.org/0000-0002-9667-6974

DOI:

https://doi.org/10.46542/pe.2022.221.265275

Keywords:

Knowledge, Naloxone, Opioids training programme, Opioids overdose, Prescribers’ awareness

Abstract

Background: Knowledge and attitudes of healthcare providers regarding opioid toxicity are significant concerns.  

Objective: Investigate the knowledge, attitudes, awareness, and comfort level regarding overdosing among a sample of healthcare providers working at the Armed Forces Hospital Southern Region (AFHSR).    

Methods: Anonymous surveys were administered to AFHSR staff to assess attitude, knowledge, comfort level, and fear of consequences using a 5-point scale. Participants were AFHSR primary care physicians/internists, surgeons, physician assistants/advanced practice registered nurses, and pharmacists.    

Results: Healthcare providers demonstrated a lack of knowledge, awareness, and fear of the consequences associated with opioid use, overdose, and the indications and administration of naloxone. This study’s findings indicate that healthcare providers are hesitant to engage in discussions with patients about preventative measures for opioid overdose, with the majority believing that doing so will make no difference in preventing opioid overdose incidence. Additionally, a distinct difference in knowledge and perceptions of opioid abuse and toxicity was found between nurses and physicians. Further, the findings indicate a difference in knowledge and awareness regarding opioid overdose and toxicity between nurses and pharmacists.     

Author Biographies

Fahad Marzouq Alotaibi, Saudi Royal land forces, Clinical pharmacy, Khamis Mushayt, Saudi Arabia

  

Mohammed Fathullah Zaitoun, Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia

Pharmaceutical care administration

Rayid Shabeeb Alotabi, Ranyah hospital, Taif, Saudi Arabia

Pharmacy department

Mohammed Saeed A. Alhadi, Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia

Pharmaceutical care administration

Amani Mohammed AlShahrani, Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia

Pharmaceutical care administration

Alyah Abdullah Almoeed, Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia

Pharmaceutical care administration

Marzouq Saeed AlNasser, Armed forces hospital southern region, Khamis Mushayt, Saudi Arabia

Pharmaceutical care administration

Ghazi Bamagous, Umm AlQura university, Makkah, Saudi Arabia

Assistant professor

References

Bazazi, A. R., Zaller, N. D., Fu, J. J., & Rich, J. D. (2010). Preventing opiate overdose deaths: examining objections to take-home naloxone. Journal of health care for the poor and underserved, 21(4), 1108

Behar, E., Bagnulo, R., & Coffin, P. O. (2018). Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Preventive medicine, 114, 79-87. https://doi.org/10.1016/j.ypmed.2018.06.005

Binswanger, I. A., Koester, S., Mueller, S. R., Gardner, E. M., Goddard, K., & Glanz, J. M. (2015). Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff. Journal of general internal medicine, 30(12), 1837-1844. https://doi.org/10.1007/s11606-015-3394-3

Bohnert, A. S., Valenstein, M., Bair, M. J., Ganoczy, D., McCarthy, J. F., Ilgen, M. A., & Blow, F. C. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305(13), 1315-1321. https://doi.org/10.1001/jama.2011.370

Bounthavong, M., Suh, K., Christopher, M. L., Veenstra, D. L., Basu, A., & Devine, E. B. (2020). Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment. Research in Social and Administrative Pharmacy, 16(8), 1033-1040. https://doi.org/10.1016/j.sapharm.2019.10.015

Coe, M. A., & Walsh, S. L. (2015). Distribution of naloxone for overdose prevention to chronic pain patients. Preventive medicine, 80, 41-43. https://doi.org/10.1016/j.ypmed.2015.05.016

Coffin, P. O., Behar, E., Rowe, C., Santos, G. M., Coffa, D., Bald, M., & Vittinghoff, E. (2016). Nonrandomized intervention study of naloxone co-prescription for primary care patients receiving long-term opioid therapy for pain. Annals of internal medicine, 165(4), 245-252. https://doi.org/10.7326/M15-2771

Darke, S., & Hall, W. (1997). The distribution of naloxone to heroin users. Addiction, 92(9), 1195-1200. https://doi.org/10.1111/j.1360-0443.1997.tb03681.x

Devries, J., Rafie, S., & Polston, G. (2017). Implementing an overdose education and naloxone distribution program in a health system. Journal of the American Pharmacists Association, 57(2), S154-S160. https://doi.org/10.1016/j.japh.2017.01.002

Dixit, D., Endicott, J., Burry, L., Ramos, L., Yeung, S. Y. A., Devabhakthuni, S., ... & Bulloch, M. N. (2016). Management of acute alcohol withdrawal syndrome in critically ill patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(7), 797-822. https://doi.org/10.1002/phar.1770

Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—the United States, 2016. JAMA, 315(15), 1624-1645. https://doi.org/10.1001/jama.2016.1464

Doyon, S., Aks, S. E., & Schaeffer, S. (2014). Expanding access to naloxone in the United States. Clinical Toxicology, 52(10), 989-992. https://doi.org/10.3109/15563650.2014.968657

Dwyer, K. H., Samuels, L., Moore, R. L., Langlois, B. K., Mitchell, P. M., Grimsman, J., & Bernstein, E. (2013). Physician attitudes and perceived barriers to prescribing nasal naloxone rescue kits in the emergency department. Annals of Emergency Medicine, 62(4), S43. https://doi.org/10.1016/j.annemergmed.2013.07.400

Foldes, F. F. (1964). The human pharmacology and clinical use of narcotic antagonists. Medical Clinics of North America, 48(2), 421-443. https://doi.org/10.1016/S0025-7125(16)33474-5

Gatewood, A. K., Van Wert, M. J., Andrada, A. P., & Surkan, P. J. (2016). Academic physicians' and medical students' perceived barriers toward bystander administered naloxone as an overdose prevention strategy. Addictive behaviors, 61, 40-46. https://doi.org/10.1016/j.addbeh.2016.05.013

Giglio, R. E., Li, G., & DiMaggio, C. J. (2015). Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Injury epidemiology, 2(1), 1-9. https://doi.org/10.1186/s40621-015-0041-8

Glanz, J. M., Narwaney, K. J., Mueller, S. R., Gardner, E. M., Calcaterra, S. L., Xu, S., ... & Binswanger, I. A. (2018). Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy. Journal of general internal medicine, 33(10), 1646-1653. https://doi.org/10.1007/s11606-017-4288-3

Green, T. C., Bowman, S. E., Zaller, N. D., Ray, M., Case, P., & Heimer, R. (2013). Barriers to medical provider support prescription naloxone as overdose antidote for lay responders. Substance use & misuse, 48(7), 558-567. https://doi.org/10.3109/10826084.2013.787099

Haffajee, R. L., & French, C. A. (2019). Provider perceptions of system-level opioid prescribing and addiction treatment policies. Current opinion in psychology, 30, 65-73. https://doi.org/10.1016/j.copsyc.2019.01.018

Haug, N. A., Bielenberg, J., Linder, S. H., & Lembke, A. (2016). Assessment of provider attitudes toward# naloxone on Twitter. Substance abuse, 37(1), 35-41. https://doi.org/10.1080/08897077.2015.1129390

Hsu, D. J., McCarthy, E. P., Stevens, J. P., & Mukamal, K. J. (2017). Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001–12. Addiction, 112(9), 1558-1564. https://doi.org/10.1111/add.13795

Kunins, H. V., Sohler, N. L., Giovanniello, A., Thompson, D., & Cunningham, C. O. (2013). A buprenorphine education and training program for primary care residents: implementation and evaluation. Substance abuse, 34(3), 242-247. https://doi.org/10.1080/08897077.2012.752777

Mattson, C. L., Schieber, L., Scholl, L., Rudd, R. A., Seth, P., Xu, L., ... & Paulozzi, L. J. (2017). Annual surveillance report of drug-related risks and outcomes—the United States, 2017

McDonald, R., & Strang, J. (2016). Are take‐home naloxone programmes effective? Systematic review utilizing the application of the Bradford Hill criteria. Addiction, 111(7), 1177-1187. https://doi.org/10.1111/add.13326

Monteiro, K., Dumenco, L., Collins, S., Bratberg, J., MacDonnell, C., Jacobson, A., ... & George, P. (2017). An interprofessional education workshop to develop health professional student opioid misuse knowledge, attitudes, and skills. Journal of the American Pharmacists Association, 57(2), S113-S117

Mueller, S. R., Koester, S., Glanz, J. M., Gardner, E. M., & Binswanger, I. A. (2017). Attitudes toward naloxone prescribing in clinical settings: a qualitative study of patients prescribed high dose opioids for chronic non-cancer pain. Journal of general internal medicine, 32(3), 277-283. https://doi.org/10.1016/j.japh.2016.12.069

Peckham, A. M., Niculete, M. E., Steinberg, H., & Boggs, D. L. (2018). A survey of prescribers' attitudes, knowledge, comfort, and fear of consequences related to opioid overdose education and naloxone distribution program. Journal of public health management and practice, 24(4), 310-317. https://doi.org/10.1097/PHH.0000000000000668

Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in drug and opioid overdose deaths—the United States, 2000–2014. Morbidity and mortality weekly report, 64(50-51), 1378-1382. https://doi.org/10.15585/mmwr.mm6450a3

Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths—the United States, 2013–2017. Morbidity and Mortality Weekly Report, 67(51-52), 1419. https://doi.org/10.15585/mmwr.mm675152e1

Sporer, K. A. (2003). Strategies for preventing heroin overdose. BMJ, 326(7386), 442-444. https://doi.org/10.1136/bmj.326.7386.442

Strang, J., McDonald, R., Campbell, G., Degenhardt, L., Nielsen, S., Ritter, A., & Dale, O. (2019). Take-home naloxone for the emergency interim management of opioid overdose: the public health application of an emergency medicine. Drugs, 79(13), 1395-1418. https://doi.org/10.1007/s40265-019-01154-5

Thakur, T., Frey, M., & Chewning, B. (2020). Pharmacist roles, training, and perceived barriers in naloxone dispensing: a systematic review. Journal of the American Pharmacists Association, 60(1), 178-194. https://doi.org/10.1016/j.japh.2019.06.016

Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., ... & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ, 346. https://doi.org/10.1136/bmj.f174

Wermeling, D. P. (2013). A response to the opioid overdose epidemic: naloxone nasal spray. Drug delivery and translational research, 3(1), 63-74. https://doi.org/10.1007/s13346-012-0092-0

Wheeler, E., Jones, T. S., Gilbert, M. K., & Davidson, P. J. (2015). Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR. Morbidity and mortality weekly report, 64(23), 631

Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., ... & Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. The lancet, 382(9904), 1575-1586. https://doi.org/10.1016/S0140-6736(13)61611-6

Winstanley, E. L., Clark, A., Feinberg, J., & Wilder, C. M. (2016). Barriers to implementation of opioid overdose prevention programs in Ohio. Substance abuse, 37(1), 42-46. https://doi.org/10.1080/08897077.2015.1132294

Yarlagadda, K., Kim, J., Kanderi, T., Sendil, S., & Nookala, V. K. (2020). Opioid antidote induced pulmonary edema and lung injury. Respiratory medicine case reports, 30, 101107. https://doi.org/10.1016/j.rmcr.2020.101107

Downloads

Published

2022-04-08

How to Cite

Alotaibi, F. M., Zaitoun, M. F. . ., Alotabi, R. S. ., Alhadi, M. S. A. . ., AlShahrani, A. M. . ., Almoeed, A. A. ., AlNasser, M. S. ., & Bamagous, G. . (2022). RESEARCH ARTICLE: Assessment of knowledge and awareness regarding opioid overdose and toxicity among a sample of healthcare providers. Pharmacy Education, 22(1), p. 265–275. https://doi.org/10.46542/pe.2022.221.265275

Issue

Section

Research Article